Insider · CIK 0001928994
Revankar Shriram
Reports to the SEC for 1 company · SAN FRANCISCO, CA
Transactions
29
Companies
1
Filings
10
CIK
0001928994
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-08-14 | DLBDolby Laboratories, Inc.S Sale | −$188K |
| 2026-05-18 | DLBDolby Laboratories, Inc.F Tax Payment | −$235K |
| 2026-05-15 | DLBDolby Laboratories, Inc.S Sale | −$165K |
| 2026-02-17 | DLBDolby Laboratories, Inc.S Sale | −$198K |
| 2025-12-16 | DLBDolby Laboratories, Inc.F Tax Payment | −$152K |
| 2025-12-15 | DLBDolby Laboratories, Inc.A Award | — |
| 2025-12-15 | DLBDolby Laboratories, Inc.M Exercise/Conversion | — |
| 2025-12-15 | DLBDolby Laboratories, Inc.F Tax Payment | −$335K |
| 2025-12-15 | DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award | — |
| 2025-12-15 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2025-12-15 | DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitM Exercise/Conversion | — |
| 2025-11-21 | DLBDolby Laboratories, Inc.S Sale | −$197K |
| 2025-08-22 | DLBDolby Laboratories, Inc.S Sale | −$524K |
| 2025-05-16 | DLBDolby Laboratories, Inc.F Tax Payment | −$334K |
| 2024-12-16 | DLBDolby Laboratories, Inc.A Award | — |
| 2024-12-16 | DLBDolby Laboratories, Inc.F Tax Payment | −$266K |
| 2024-12-16 | DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award | — |
| 2024-12-16 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2024-05-16 | DLBDolby Laboratories, Inc.F Tax Payment | −$369K |
| 2023-12-15 | DLBDolby Laboratories, Inc.A Award | — |
| 2023-12-15 | DLBDolby Laboratories, Inc.F Tax Payment | −$116K |
| 2023-12-15 | DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award | — |
| 2023-12-15 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2023-05-16 | DLBDolby Laboratories, Inc.F Tax Payment | −$361K |
| 2022-12-15 | DLBDolby Laboratories, Inc.A Award | — |
| 2022-12-15 | DLBDolby Laboratories, Inc. · Performance-Based Restricted Stock UnitA Award | — |
| 2022-12-15 | DLBDolby Laboratories, Inc. · Employee Stock Option (Right to Buy)A Award | — |
| 2022-05-16 | DLBDolby Laboratories, Inc.A Award | — |
| 2022-05-16 | DLBDolby Laboratories, Inc. · Employee Stock Option (right to buy)A Award | — |
Recent filings
- 4Revankar Shriram0001193125-26-355688SEC(opens sec.gov)
- 4Revankar Shriram0001193125-26-231170SEC(opens sec.gov)
- 4Revankar Shriram0001193125-26-055277SEC(opens sec.gov)
- 4Revankar Shriram0001193125-25-323427SEC(opens sec.gov)
- 4Revankar Shriram0001193125-25-293782SEC(opens sec.gov)
- 4Revankar Shriram0000950170-25-111534SEC(opens sec.gov)
- 4Revankar Shriram0000950170-25-075218SEC(opens sec.gov)
- 4Revankar Shriram0000950170-24-138165SEC(opens sec.gov)
- 4Revankar Shriram0000950170-24-062013SEC(opens sec.gov)
- 4Revankar Shriram0001209191-23-059257SEC(opens sec.gov)
Companies
Address
C/O DOLBY LABORATORIES, INC. 1275 MARKET STREET
SAN FRANCISCO, CA, 94103